GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » ROE % Adjusted to Book Value

Cresco Labs (Cresco Labs) ROE % Adjusted to Book Value : -2.92% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs ROE % Adjusted to Book Value?

Cresco Labs's ROE % for the quarter that ended in Mar. 2024 was -4.12%. Cresco Labs's PB Ratio for the quarter that ended in Mar. 2024 was 1.41. Cresco Labs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -2.92%.


Cresco Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Cresco Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs ROE % Adjusted to Book Value Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.64 -6.64 -20.24 -35.66 -34.05

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.68 -28.99 -60.63 2.29 -2.92

Competitive Comparison of Cresco Labs's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cresco Labs's ROE % Adjusted to Book Value falls into.



Cresco Labs ROE % Adjusted to Book Value Calculation

Cresco Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-30.99% / 0.91
=-34.05%

Cresco Labs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.12% / 1.41
=-2.92%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cresco Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (Cresco Labs) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.